N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Titel:
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Auteur:
Tan, W.W. Hillman, D.W. Salim, M. Northfelt, D.W. Anderson, D.M. Stella, P.J. Niedringhaus, R. Bernath, A.M. Gamini, S.S. Palmieri, F. Perez, E.A.